Adenosine-to-inosine RNA editing in cancer: molecular mechanisms and downstream targets

Area of Science:

• Molecular Biology
• Genetics
• Biochemistry

Background:

• Adenosine-to-Inosine (A-to-I) RNA editing is a prevalent post-transcriptional modification impacting RNA structure and function.
• A-to-I editing influences diverse RNA types, including mRNA, tRNA, miRNA, and viral RNA, affecting biological and pathological processes.
• Aberrant A-to-I levels are linked to human diseases, particularly cancer, by regulating oncogenes and tumor suppressor genes.

Purpose of the Study:

• To review recent advancements in understanding A-to-I editing pathways in cancer.
• To elucidate the biological functions of A-to-I editing in the context of tumorigenesis and progression.
• To connect the molecular mechanisms of A-to-I modification to cancer development and progression.

Main Methods:

• Literature review of current research on A-to-I editing in cancer.
• Analysis of studies investigating the role of A-to-I editing enzymes and pathways.
• Synthesis of findings on the impact of A-to-I editing on gene expression in cancer.

Main Results:

• A-to-I editing significantly impacts cancer development and progression.
• Specific A-to-I editing events regulate key cancer-related genes.
• Dysregulation of A-to-I editing pathways contributes to oncogenesis.

Conclusions:

• A-to-I editing represents a critical layer of gene regulation in cancer.
• Further research into A-to-I editing mechanisms is essential for understanding cancer biology.
• Targeting A-to-I editing pathways may offer novel therapeutic strategies for cancer treatment.